Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

A novel combination of an investigational intravesical drug delivery system designed to provide sustained release of gemcitabine into the bladder (Gem-iDRS, Inlexzo) and systemic treatment with the ...

Amini: The majority of these patients — except at this time stage 1 — will need systemic therapy as part of their therapy, ...

The phase 2, single-arm INDIBLADE trial assessed induction ipilimumab plus nivolumab followed by CRT in patients with MIBC.

DOC1021 is a first-in-class, patient-derived double-loaded dendritic cell therapy that combines tumor lysate and amplified tumor-derived mRNA. The immunotherapy is made with a patient's dendritic ...

With the advancement of imaging technologies, the application of 18 F-FDG PET/CT in the diagnosis and management of cervical ...

Dizon, MD, FACP, FASCO, shared insights on what pregnancy looks like with a breast cancer diagnosis and what those considering pregnancy should know. For young patients with breast cancer, pregnancy ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

"We are still learning how best to use immunotherapy in limited-stage, small-cell lung cancer. Concurrent immunotherapy with chemoradiotherapy did not improve survival, but we did not find worsened ...

aDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands bDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, ...

aDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China bDepartment of Radiation Oncology, ...